The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Does The Market Size Of The Heart Attack Diagnostic Market Compare Between 2026 And 2030?
The heart attack diagnostic market has demonstrated robust expansion in recent years. Forecasts indicate it will expand from $11.54 billion in 2025 to $12.64 billion in 2026, registering a compound annual growth rate (CAGR) of 9.5%. Historically, this growth can be ascribed to factors such as the increasing prevalence of cardiovascular diseases, the enhancement of hospital diagnostic capabilities, greater availability of cardiac imaging technologies, heightened awareness regarding early heart attack detection, and progress in laboratory testing methods.
The heart attack diagnostic market size is expected to undergo significant expansion in the coming years. It is forecast to grow to $17.9 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.1%. This anticipated growth over the forecast period stems from the increasing demand for swift diagnostic solutions, the expanding integration of digital health platforms, the growth of remote cardiac monitoring, rising investments in advanced imaging technologies, and the increasing adoption of precision cardiology diagnostics. Prominent trends for the forecast period include the increasing uptake of AI-assisted diagnostic tools, the rising utilization of high-sensitivity cardiac biomarkers, the growing integration of point-of-care testing devices, the expansion of non-invasive diagnostic procedures, and an enhanced focus on rapid emergency diagnostics.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8498&type=smp
Which Strong Drivers Are Impacting The Heart Attack Diagnostic Market Growth?
The escalating incidence of cardiac disorders is driving the growth of the heart attack diagnostics market. Cardiac disorders (CVD) refer to a range of conditions affecting the heart and blood vessels. Unhealthy diets, lack of physical activity, use of tobacco products, and alcohol abuse are primary contributors to heart disease and stroke. Heart attack diagnosis aids in understanding the causes and severity of heart attacks, strokes, and heart failure. For instance, in January 2024, the American Heart Association, a US-based non-profit organization, reported that the age-adjusted death rate from cardiovascular disease increased to 233.3 per 100,000 in 2024, marking a 4.0% rise from 224.4 per 100,000 in 2023. Thus, the growing frequency of cardiovascular illnesses will continue to propel the heart attack diagnostics market.
Which Segment Classifications Are Used In The Heart Attack Diagnostic Market Segment Analysis?
The heart attack diagnostic market covered in this report is segmented –
1) By Test Type: Electrocardiogram (ECG Or EKG), Blood Tests, Echocardiogram, Coronary Catheterization (Angiogram)
2) By Procedure: Invasive Procedure, Non-Invasive Procedure
3) By End-Use Industry: Hospitals, Ambulatory Surgical Centers, Diagnostics Centers, Other End-Users
Subsegments:
1) By Electrocardiogram (ECG Or EKG): Resting ECG, Holter Monitor, Event Monitor
2) By Blood Tests: Cardiac Biomarkers, Lipid Panel, B-Type Natriuretic Peptide (BNP)
3) By Echocardiogram: Transthoracic Echocardiogram (TTE), Transesophageal Echocardiogram (TEE), Doppler Echocardiogram
4) By Coronary Catheterization (Angiogram): Coronary Angiography, Right Heart Catheterization, Left Heart Catheterization
Which Trends Are Contributing To Changes In The Heart Attack Diagnostic Market?
Leading companies within the heart attack diagnostics market are actively developing innovative products, such as coronary heart disease detection tests, to cater to expanded customer bases, generate increased sales, and boost revenue. Coronary heart disease (CHD) detection tests refer to medical assessments and diagnostic procedures specifically designed to identify the presence of coronary heart disease, a condition characterized by the narrowing or blockage of the coronary arteries that supply blood to the heart muscle. For instance, in August 2023, Cardio Diagnostics Holdings Inc., a US-based biotechnology company, unveiled PrecisionCHD. The PrecisionCHD test, a significant innovation, is a blood-based method for detecting coronary heart disease (CHD), distinguished as the only detection technology that seamlessly integrates epigenetic and genetic biomarkers with Artificial Intelligence (AI). This unique test requires only a straightforward blood sample, which can be conveniently collected at a doctor’s office or through a simple at-home procedure, and it utilizes the same highly scalable laboratory technique employed in COVID-19 testing. With results ready for review within a swift 10 business days, the PrecisionCHD test presents a rapid and efficient alternative to conventional first-line CHD detection tools like stress echocardiograms.
Which Firms Are Contributing To The Heart Attack Diagnostic Market Ecosystem?
Major companies operating in the heart attack diagnostic market are Abbott Laboratories, F. Hoffmann-La Roche AG, General Electric Co., Koninklijke Philips NV, Siemens AG, Canon Medical Systems Corporation, GE Healthcare, Roche Diagnostics, Beckman Coulter Inc., Schiller AG, Becton Dickinson and Company, Danaher Corporation, Thermo Fisher Scientific Inc., Quest Diagnostics, Bio-Rad Laboratories Inc., Hitachi Ltd., Toshiba Corp., Fujifilm Holdings, Midmark Corp., Welch Allyn Inc., HILL ROM HOLDINGS Inc., HeartFlow, Cardio Diagnostics Holdings Inc.
Get The Full Heart Attack Diagnostic Market Report:
https://www.thebusinessresearchcompany.com/report/heart-attack-diagnostic-global-market-report
Where Is The Heart Attack Diagnostic Market Most Concentrated Geographically?
North America was the largest region in the heart attack diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the heart attack diagnostic market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Heart Attack Diagnostic Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/customise?id=8498&type=smp
Browse Through More Reports Similar to the Global Heart Attack Diagnostic Market 2026, By The Business Research Company
Cardiac Biomarkers Market Report 2026
https://www.thebusinessresearchcompany.com/report/cardiac-biomarkers-global-market-report
Cardiac Biomarkers Testing Market Report 2026
https://www.thebusinessresearchcompany.com/report/cardiac-biomarkers-testing-global-market-report
Cardiovascular Clinical Trials Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model